Daptomycin non-susceptible, vancomycin-intermediate Staphylococcus aureus endocarditis treated with ceftaroline and daptomycin: case report and brief review of the literature-Reference-Cited by-同舟云学术

Daptomycin non-susceptible, vancomycin-intermediate Staphylococcus aureus endocarditis treated with ceftaroline and daptomycin: case report and brief review of the literature

Published:2015-03-25 Issue:6 Volume:43 Page:751-754
ISSN:0300-8126
Container-title:Infection
language:en
Short-container-title:Infection

Author:

Baxi Sanjiv M.,Chan Dominic,Jain Vivek

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s15010-015-0763-0.pdf

Reference22 articles.

1. Loomba PS, Taneja J, Mishra B. Methicillin and vancomycin resistant S. aureus in hospitalized patients. J Glob Infect Dis. 2010;2:275–83. doi: 10.4103/0974-777X.68535 .

2. Saravolatz LD, Pawlak J, Johnson LB. In vitro susceptibilities and molecular analysis of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus isolates. Clin Infect Dis. 2012;55:582–6. doi: 10.1093/cid/cis492 .

3. Cui L, Tominaga E, Neoh HM, Hiramatsu K. Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus. Antimicrob Agents Chemother. 2006;50:1079–82. doi: 10.1128/AAC.50.3.1079-1082.2006 .

4. Bhalodi AA, Hagihara M, Nicolau DP, Kuti JL. In vitro pharmacodynamics of human simulated exposures of ceftaroline and daptomycin against MRSA, hVISA, and VISA with and without prior vancomycin exposure. Antimicrob Agents Chemother. 2014;58:672–7. doi: 10.1128/AAC.01516-13 .

5. Dhand A, Bayer AS, Pogliano J, Yang SJ, Bolaris M, Nizet V, et al. Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding. Clin Infect Dis. 2011;53:158–63. doi: 10.1093/cid/cir340 .

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Antimicrobials and New Therapy Strategies for Endocarditis: Weapons That Should Be Defended;Journal of Clinical Medicine;2023-12-14

2. Heartbreaking Decisions: The Dogma and Uncertainties of Antimicrobial Therapy in Infective Endocarditis;Pathogens;2023-05-12

3. Physiologically based pharmacokinetic modelling to inform combination dosing regimens of ceftaroline and daptomycin in special populations;British Journal of Clinical Pharmacology;2023-05-11

4. Emerging resistance mechanisms for 4 types of common anti-MRSA antibiotics in Staphylococcus aureus: A comprehensive review;Microbial Pathogenesis;2021-07

5. Updates on Combination Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia;Current Infectious Disease Reports;2020-09-09